跳至主要内容
临床试验/IRCT20190608043840N1
IRCT20190608043840N1招募中3 期

Evaluation of efficacy of Maa-al-shaeer (An Iranian medicine product based on barley seeds) in preventing and reducing the severity of radiotherapy-induced dysuria in prostate cancer patients; a double-blind randomized clinical trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Male

入选标准

  • •Over 18 years old
  • •Prostate cancer
  • •Candidate for radiation therapy (at the Radiotherapy Center of Shohada-e-Tajrish Hospital)
  • •Consciousness

排除标准

  • •Unconsciousness or unable to report dysuria
  • •Urinary catheter
  • •Urinary tract infection
  • •Diabetes Mellitus
  • •A history of drug sensitivity
  • •Chemotherapy at the same time
  • •Severe Cardiovascular, Pulmonary, Hepatic and Kidney diseases that need some medical treatments
  • •Not participating in the study

研究者

相似试验

Evaluation of the efficacy of Maa-al-shaeer (product... | 临床试验